Company: LRHC
Filing Date: 2025-08-11
Form Type: S-1
Source: 0001213900-25-074405
Chunk: 44

Company: La Rosa Holdings Corp.
Filing Date: 2025-08-11
Form: S-1
Chunk 44
---
 sales of Advance Shares under the Facility will depend on a variety of factors to be determined
by the Company from time to time, which may include, without limitation, market conditions, the trading price of the common stock and
determinations by the Company as to the appropriate sources of funding for its business and operational needs. The net proceeds under
the Facility to the Company will depend on the frequency and prices at which the Company sells Advance Shares to the Selling Stockholder.

The Selling Stockholder will not be required to subscribe for any Advance
Shares under the Facility Agreement which, when aggregated with all other Shares then beneficially owned by the Selling Stockholder and
its affiliates (as calculated pursuant to Section 13(d) of the Exchange Act, and Rule 13d-3 promulgated thereunder), would result in the
beneficial ownership by the Selling Stockholder and its affiliates to exceed 4.99% (which the Selling Stockholder, upon notice to the
Company, may increase or decrease but in no event in excess of 9.99%) of the outstanding voting power or number of the Common Stock. As
of August 4, 2025, the Selling Stockholder beneficially owned no shares of our common stock.

The Facility Agreement contains customary representations,
warranties, conditions and indemnification obligations of the parties.

A.G.P./Alliance Global Partners and Curvature
Securities, LLC acted as placement agents in connection with the transactions contemplated by the Facility Agreement, for which the Company
has agreed to pay a cash compensation equal to 1.4985 and 0.1665%, respectively, of the proceeds of the Company received pursuant to the
Facility at the time of the placement of the Advance Shares issued thereunder.

<div align='center'>24</div>

The Company cannot effect any sales under the
Facility and the Selling Stockholder will not have any obligation to purchase Advance Shares under the Facility to the extent that after giving effect to
such purchase and sale the aggregate number of Advance Shares issued under the Facility together with any shares of common stock issued
in connection with any other transaction that may be considered part of the same series of transactions, where the number of shares issued
would exceed the number of shares representing 19.99% of the issued and outstanding shares of common stock as of the date of the Facility
(the “Exchange Cap”), unless the Company has obtained stockholder approval as required for issuance of common stock in excess
of the Exchange Cap, in accordance